Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients
Acta Pharmacologica Sinica2013Vol. 34(4), pp. 570–580
Citations Over Time
Zhixiang Zhuang, Hong Zhu, Ji Wang, Mingao Zhu, Hui Wang, Wangyang Pu, Huahui Bian, Lei Chen, Hong Zhang
Related Papers
- → Folinic Acid Does Improve 5-Fluorouracil ActivityIn Vivo.Results of a Phase III Study Comparing 5-Fluorouracil to 5-Fluorouracil and Folinic Acid in Advanced Colon Cancer Patients(1993)22 cited
- → The increasing doses of methotrexate pharmacokinetics after intravenous administration in rats - model selection(2019)3 cited
- Pharmacokinetics of monoclonal antibody HAb 18 and its F(ab^)_(2) and fab fragments in mice(1996)
- Pharmacokinetics and tissue distribution of Chuanhuning emuslion in rats(2014)
- → A Prospective Randomised Multicentre Phase III Clinical Trial Comparing the Effects of Panorex Injection Plus 5-Fluorouracil (5-FU)/Leucovorin versus 5-Fluorouracil/Leucovorin versus PANOREX alone, in patients with Surgically resected Stage III (Dukes C) Carcinoma of the Colon(2012)